Prelude Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,600	Closed	-$304K	–	986
2023 Q3	$304K	Buy	16,600 +6,500	+64%	+$119K	0.02%	559
2023 Q2	$218K	Buy	10,100 +2,800	+38%	+$60.4K	0.01%	695
2023 Q1	$214K	Buy	+7,300	New	+$214K	0.01%	741